Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33Colorectal Neoplasms 13Neoplasms 11Pain, Postoperative 10Lung Neoplasms 9Brain Neoplasms 8Stomach Neoplasms 7Prostatic Neoplasms 7Pancreatic Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Melanoma 6Leukemia, Myeloid, Acute 5Ovarian Neoplasms 4Myoma 4Lymphoma, Non-Hodgkin 4Leiomyoma 4Hemorrhage 4Head and Neck Neoplasms 4Glioblastoma 4Colonic Neoplasms 4Agnosia 4Skin Neoplasms 3Recurrence 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neurotoxicity Syndromes 3Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Myelodysplastic Syndromes 3Multiple Endocrine Neoplasia Type 1 3

Interventions

Misoprostol 5Uterine Myomectomy 3Saline Solution 3relugolix 2dienogest 2carbetocin 2Uterine Artery Embolization 2Tranexamic Acid 2Tourniquets 2Lidocaine 2Leuprolide 2Ascorbic Acid 2ulipristal 1telapristone acetate 1ramosetron 1pirfenidone 1estradiol, norethindrone drug combination 1Vasopressins 1Triptorelin Pamoate 1Tablets 1Sodium Chloride 1Sevoflurane 1Respiration, Artificial 1Remifentanil 1Propofol 1Population Groups 1Oxytocin 1Nuclear Receptor Subfamily 4, Group A, Member 2 1Morcellation 1Methylergonovine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Myofibroma × Sodium Chloride × Clear all
NCT04482959 2022-04-06

Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy

Mansoura University Hospital

Phase 4 Completed
40 enrolled

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡